BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
4243277
Number of visits today
946
Number of downloads
3882534
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Cheng L, Zhang S, Wang M, Lopez-Beltran A. Biological and clinical perspectives of TERT promoter mutation detection on bladder cancer diagnosis and management. Hum Pathol 2022:S0046-8177(22)00150-2. [PMID: 35700749 DOI: 10.1016/j.humpath.2022.06.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu T, Li S, Xia C, Xu D. TERT promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significance. Front Immunol 2022;13:1071390. [PMID: 36713366 DOI: 10.3389/fimmu.2022.1071390] [Reference Citation Analysis]
2 Gupta S, Cheng L, Erickson LA. Contemporary Updates in Urologic Pathology: A Special Issue of Renal, Urinary Tract, Prostate, Penile & Testicular Pathology. Human Pathology 2022. [DOI: 10.1016/j.humpath.2022.10.001] [Reference Citation Analysis]
3 Walker JM, O’malley P, He M. Applications of Exosomes in Diagnosing Muscle Invasive Bladder Cancer. Pharmaceutics 2022;14:2027. [DOI: 10.3390/pharmaceutics14102027] [Reference Citation Analysis]
4 Mohanty SK, Lobo A, Cheng L. The 2022 revision of World Health Organization classification of tumors of the urinary system and male genital organs: advances and challenges. Hum Pathol 2022:S0046-8177(22)00224-6. [PMID: 36084769 DOI: 10.1016/j.humpath.2022.08.006] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345